Sachin Punatar

13PUBLICATIONS
27CO-AUTHORS
Aerospace structuresMedical infection agents (incl. prions)Medical mycologyCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Feb 20, 2026
Validation and Refinement of the European LeukemiaNet 2022 Genetic Risk Stratification of AML.

Gojiri Mawalankar, Aarti Achrekar, Seema Biswas

|Jan 08, 2026
Is Less "Sufficient" and "Safe" in the MRD Era - Outcomes of Autologous Stem-Cell Transplant as per Melphalan Dose in Patients with Multiple Myeloma.

Sumeet Mirgh, Arti Goel, Sachin Punatar

|Dec 12, 2025
Multiple Myeloma in Young Adults-Insights From a Tertiary Care Cancer Centre in India.

George John, Sumeet Mirgh, Sachin Punatar

|Nov 01, 2025
Treatment free remission (TFR) in chronic myeloid leukemia-results, compliance and patterns of failure from a tertiary care cancer centre in India.

Sachin Punatar, Nishant Jindal, Anant Gokarn

|May 20, 2025
Correction: Novel humanized CD19-CAR-T (Now talicabtagene autoleucel, Tali-cel™) cells in relapsed/ refractory pediatric B-acute lymphoblastic leukemia- an open-label single-arm phase-I/Ib study.

Gaurav Narula, Swaminathan Keerthivasagam, Hasmukh Jain

|Apr 24, 2025
Novel humanized CD19-CAR-T (Now talicabtagene autoleucel, Tali-cel™) cells in relapsed/ refractory pediatric B-acute lymphoblastic leukemia- an open-label single-arm phase-I/Ib study.

Gaurav Narula, Swaminathan Keerthivasagam, Hasmukh Jain

Pageof 3

Frequent Collaborators

9 joint publications

Navin Khattry

8 joint publications

Bhausaheb Bagal

8 joint publications

Sumeet Mirgh

5 joint publications

Prashant Tembhare